Back
Cue Biopharma Vs. FibroGen Industry Stock Comparison
Sell
16
CUE
Cue Biopharma
Last Price:
1.04
Seasonality Move:
13.31%
Sell
46
FGEN
FibroGen
Last Price:
0.39
Seasonality Move:
88.99%
Sell
16
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $0.35. The Score for FGEN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight selling pressure.
FGEN Stock Price Chart
CUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 39.31 | Sell |
Chaikin Money Flow: | -136595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.28 - 1.76) | Sell |
Bollinger Bands (100): | (0.57 - 1.35) | Buy |
FGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 51.19 | Buy |
Chaikin Money Flow: | 258590 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.3 - 0.36) | Buy |
Bollinger Bands (100): | (0.24 - 0.78) | Sell |
CUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.38 | Sell |
20-day SMA: | 1.54 | Sell |
50-day SMA: | 1.16 | Sell |
200-day SMA: | 1.39 | Sell |
8-day EMA: | 1.3 | Sell |
20-day EMA: | 1.41 | Sell |
50-day EMA: | 1.26 | Sell |
200-day EMA: | 1.46 | Sell |
FGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.33 | Buy |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 1.04 | Sell |
8-day EMA: | 0.34 | Buy |
20-day EMA: | 0.34 | Buy |
50-day EMA: | 0.38 | Sell |
200-day EMA: | 1.24 | Sell |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.
Cue Biopharma Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
FibroGen Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |